Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,332 | 806 | 86.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,020 | 1 | 7.1% |
| Education | $773.78 | 11 | 5.4% |
| Travel and Lodging | $154.35 | 3 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $2,247 | 122 | $0 (2024) |
| ABBVIE INC. | $2,005 | 146 | $0 (2024) |
| Incyte Corporation | $1,717 | 29 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,077 | 54 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $927.85 | 47 | $0 (2024) |
| Lilly USA, LLC | $744.35 | 56 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $684.49 | 33 | $0 (2024) |
| Dermavant Sciences, Inc. | $678.63 | 46 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $664.18 | 55 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $556.68 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,159 | 245 | Incyte Corporation ($1,416) |
| 2023 | $3,416 | 226 | Janssen Biotech, Inc. ($745.21) |
| 2022 | $3,532 | 202 | ABBVIE INC. ($727.86) |
| 2021 | $2,173 | 148 | Janssen Biotech, Inc. ($421.97) |
All Payment Transactions
821 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Immunology | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Immunology | ||||||
| 12/10/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.71 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Immunology | ||||||
| 11/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $9.08 | General |
| Category: Dermatology | ||||||
| 11/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $1.63 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,150 | 1,588 | $308,883 | $80,506 |
| 2022 | 16 | 804 | 1,169 | $189,350 | $55,605 |
| 2021 | 14 | 616 | 850 | $139,341 | $43,493 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 163 | 205 | $64,349 | $16,007 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 205 | 261 | $47,589 | $15,004 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 177 | $42,807 | $14,329 | 33.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 135 | 149 | $45,177 | $8,765 | 19.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 134 | 171 | $34,082 | $5,665 | 16.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 14 | 15 | $10,811 | $3,281 | 30.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 48 | 48 | $10,899 | $3,270 | 30.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 75 | 86 | $10,289 | $3,258 | 31.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $9,397 | $2,921 | 31.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 16 | $5,693 | $1,942 | 34.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 83 | 304 | $8,010 | $1,492 | 18.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 30 | 37 | $5,072 | $1,301 | 25.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $5,406 | $997.37 | 18.4% |
| 10040 | Acne surgery | Office | 2023 | 11 | 11 | $2,385 | $867.48 | 36.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 21 | 26 | $3,969 | $824.07 | 20.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 16 | 16 | $2,687 | $562.64 | 20.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 21 | 26 | $260.00 | $21.06 | 8.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 89 | 129 | $31,873 | $10,066 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 133 | 169 | $30,336 | $9,768 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 90 | $22,747 | $7,627 | 33.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 83 | 93 | $27,347 | $5,719 | 20.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 99 | 120 | $18,226 | $4,152 | 22.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 52 | 52 | $11,520 | $3,514 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $9,532 | $3,094 | 32.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 59 | 70 | $7,886 | $2,809 | 35.6% |
About Kristen Teixeira
Kristen Teixeira is a Physician Assistant healthcare provider based in Hamilton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2020. The National Provider Identifier (NPI) number assigned to this provider is 1760016638.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kristen Teixeira has received a total of $14,280 in payments from pharmaceutical and medical device companies, with $5,159 received in 2024. These payments were reported across 821 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($12,332).
As a Medicare-enrolled provider, Teixeira has provided services to 2,570 Medicare beneficiaries, totaling 3,607 services with total Medicare billing of $179,604. Data is available for 3 years (2021–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Hamilton, NJ
- Active Since 02/28/2020
- Last Updated 02/28/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1760016638
Products in Payments
- TREMFYA (Drug) $2,299
- OPZELURA (Drug) $1,717
- SKYRIZI (Biological) $1,108
- RINVOQ (Biological) $752.62
- TALTZ (Drug) $708.58
- VTAMA (Drug) $678.63
- COSENTYX (Drug) $668.06
- Sotyktu (Drug) $656.54
- DUPIXENT (Biological) $652.65
- ILUMYA (Biological) $438.54
- ADBRY (Biological) $383.61
- EUCRISA (Drug) $321.95
- SILIQ (Drug) $281.07
- Ilumya (Biological) $260.56
- COSENTYX (Biological) $259.79
- ARAZLO (Drug) $216.05
- Winlevi (Drug) $211.02
- Otezla (Drug) $168.07
- SPEVIGO (Drug) $137.91
- ENSTILAR (Drug) $135.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Hamilton
Nicole Schmid Davis, Pac, PAC
Physician Assistant — Payments: $148,193
Christina Valdez, Pa-C, PA-C
Physician Assistant — Payments: $11,005
Ms. Stephanie Higby, Pa, PA
Physician Assistant — Payments: $7,237
Jordan Hobaica
Physician Assistant — Payments: $5,083
Mr. Hugh Gapay, Pa-C, PA-C
Physician Assistant — Payments: $4,929
Mrs. Aashika Jaladi, Pa-C, PA-C
Physician Assistant — Payments: $2,963